Literature DB >> 17901368

How does the chloride/proton antiporter ClC-3 control NADPH oxidase?

Bernard Lassègue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17901368     DOI： 10.1161/CIRCRESAHA.107.161869

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  7 in total

1.  ClC-3 promotes angiotensin II-induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation.

Authors:  Guo-Zheng Liang; Li-Min Cheng; Xing-Feng Chen; Yue-Jiao Li; Xiao-Long Li; Yong-Yuan Guan; Yan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2018-07-05       Impact factor: 6.150

2.  Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Anna Dikalova; James C Slaughter; M R Kaplowitz; Y Zhang; Judy L Aschner
Journal:  Antioxid Redox Signal       Date:  2013-01-29       Impact factor: 8.401

Review 3.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

Review 4.  Chloride channels: often enigmatic, rarely predictable.

Authors:  Charity Duran; Christopher H Thompson; Qinghuan Xiao; H Criss Hartzell
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 5.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

Review 6.  Redox signaling across cell membranes.

Authors:  Aron B Fisher
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

7.  An Exploration of Charge Compensating Ion Channels across the Phagocytic Vacuole of Neutrophils.

Authors:  Juliet R Foote; Philippe Behe; Mathew Frampton; Adam P Levine; Anthony W Segal
Journal:  Front Pharmacol       Date:  2017-02-28       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.